Intercept Pharmaceuticals, Inc.
Steroids as agonists for FXR
Last updated:
Abstract:
The invention relates to compounds of formula (I): ##STR00001## wherein R is ethyl and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.
Status:
Grant
Type:
Utility
Filling date:
21 Jun 2019
Issue date:
27 Oct 2020